Order Article Reprints

Chernov AN, Skliar SS, Kim AV, Tsapieva A, Pyurveev SS, Filatenkova TA, Matsko MV, Ivanov SD, Shamova OV, Suvorov AN. Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients. Pharmaceutics. 2024; 16(9):1234. https://doi.org/10.3390/pharmaceutics16091234

Chernov, Alexander N., Sofia S. Skliar, Alexander V. Kim, Anna Tsapieva, Sarng S. Pyurveev, Tatiana A. Filatenkova, Marina V. Matsko, Sergey D. Ivanov, Olga V. Shamova, and Alexander N. Suvorov. 2024. "Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients" Pharmaceutics 16, no. 9: 1234. https://doi.org/10.3390/pharmaceutics16091234

Chernov, A. N., Skliar, S. S., Kim, A. V., Tsapieva, A., Pyurveev, S. S., Filatenkova, T. A., Matsko, M. V., Ivanov, S. D., Shamova, O. V., & Suvorov, A. N. (2024). Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients. Pharmaceutics, 16(9), 1234. https://doi.org/10.3390/pharmaceutics16091234